Drug recall D-0185-2024
Product
Jardiance (empagliflozin tablets), 25 mg, 30 tablets (3 blister cards with 10 tablets each), Rx only, Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877. NDC: 0597-0153-37
Reason for recall
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Lots and codes
Batch D41919
Recall details
- Recalling firm
- CARDINAL HEALTHCARE, Dublin, OH
- Quantity
- 1 unit
- Distribution
- Nationwide USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- January 26, 2022
- Terminated
- September 29, 2024
Related products
- Jardiance – drug information
- NDC 0597-0152 Jardiance · Empagliflozin 10 mg/1 · Boehringer Ingelheim Pharmaceuticals, Inc.
- NDC 0597-0153 Jardiance · Empagliflozin 25 mg/1 · Boehringer Ingelheim Pharmaceuticals, Inc.